Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
12/1999
12/29/1999CA2335356A1 Nitrate salts of antihypertensive medicines
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999US6008412 Reacting n-methyl-3(r,s)-hydroxy-3-phenylpropylamine with s-(+)-mandelic acid; salt formation
12/28/1999US6008158 Enhancer composition for agricultural chemicals and method for enhancing the efficacy of agricultural chemical
12/23/1999WO1999065891A1 Novel 2,4-diaminophenol derivatives and the use thereof
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065865A1 Novel 3,4-diaminophenol derivatives and their use
12/23/1999DE19822041A1 2,5-Diamino-1-phenylbenzol-Derivate enthaltende Oxidationshaarfärbemittel sowie neue 2,5-Diamino-1-phenylbenzol-Derivate 2,5-diamino-1-phenylbenzene derivatives containing oxidation hair as well as new 2,5-diamino-1-phenylbenzene derivatives
12/22/1999CN1047590C Hydrogenation process of aromatic nitro derivatives
12/21/1999US6005133 Enantioselective oxazaborolidine catalysts
12/21/1999US6004958 Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
12/21/1999US6004482 Stable aromatic amine composition, and a process for preparing color stable aromatic amines
12/21/1999CA2183160C Displacement chromatography of proteins using low molecular weight displacers
12/21/1999CA2116195C Decolorization of alkanolamines and alkyleneamines
12/21/1999CA2079720C Process for monitoring and controlling an alkanolamine reaction process
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999048461A3 Substituted aromatic compounds for treatment of antibiotic resistant infections
12/16/1999DE19826457A1 Neue 2,4-Diaminophenolderivate und deren Verwendung New 2.4-Diaminophenolderivate and their use
12/16/1999DE19826456A1 Neue 3,4-Diaminophenolderivate und deren Verwendung New 3.4-Diaminophenolderivate and their use
12/16/1999DE19826396A1 Verfahren zur Herstellung von Aminen A process for preparing amines
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999EP0963975A1 Amines preparation process
12/15/1999CN1238768A Process for preparing tolterodine
12/15/1999CN1238759A Nitrone derivatives
12/14/1999US6001884 (substituted phenylene)alkylaminealkyl phenylene compounds of given formula; administering to treat disorders characterized by abnormal calcium homeostasis such as hyperparathyroidism, paget's disease, osteoporosis and hypertension
12/09/1999WO1999062863A1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
12/09/1999WO1999062861A1 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof
12/09/1999WO1999062505A2 Method for treating neurodegenerative disorders
12/08/1999EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999CN1237575A Liquid-phase hydrogenation new technological process for preparation of P-aminophenol by using P-nitrophenol
12/08/1999CN1237574A Method for synthesizing phynylethanolamine compound
12/08/1999CN1047173C Optically active beta-aminoalkyxoborane complex
12/07/1999US5998669 Process for production of 2-amino-1,3-propanediol
12/07/1999US5998667 Chemical intermediate for insecticides, miticides
12/01/1999EP0960109A1 Process to prepare tolterodine
12/01/1999EP0773921B1 Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
11/1999
11/30/1999US5994586 Reduction of an alkyl 2-hydroxyimino-3-oxo-4-acyloxyalkanoate
11/30/1999US5994585 Amination process
11/30/1999US5994558 2-isoxazoline derivative and process for producing the same; and process for producing related derivatives from the same
11/30/1999US5994408 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
11/30/1999CA2185599C Methods for the manufacture of terbinafine, trans-n-methyl-n-(1-naphthylmethyl)-6,6-dimethylhept-2-en-4 -ynyl-1-amine and pharmaceutically acceptable salt thereof, intermediates useful in the manufacture thereof, novel n-methyl-n-(1-naphthylmethyl)-6,6-dimethyl-2-hydroxyheptan- 4-ynyl-1-amine as potential antimycotic agents
11/25/1999WO1999059527A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/24/1999EP0901480A4 Process for preparing oxiranemethanamine derivatives
11/24/1999CN1046712C Process for preparation of leukotriene antagonists
11/23/1999US5990355 Substituted diaminophenols, process for their preparation, and hair dyes containing such compounds
11/23/1999US5990164 Cardiovascular disorders, antidiabetic agents, skin diseases, antiinflammatory and -carcinogenic agents, immunological diseases, psychological and skin disorders; water soluble; nutrients; foods; topical
11/23/1999US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/23/1999US5990104 Inhibiting nmda receptor activation by administering derivatives of given formula, such as 5,6,7,8,9,11,12-heptahydro-3-hydroxy-5-methyl-10-thia-5,11 -methanobenzocyclodecen-13-amine (sulphazocine)
11/23/1999CA2116685C (-)-ritodrine
11/17/1999EP0956141A1 Amine heat stable salt neutralization having reduced solids
11/16/1999US5986140 7,8-difluoro-2,3-dihydro-3-methyl-4H-1,4-benzoxazine
11/16/1999US5986139 Process for the hydrogenation of imines
11/16/1999US5984975 3-substituted para-aminophenols and use thereof in dyeing keratinous fibers
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999CN1234392A Optically active beta-alkamine compound and use thereof
11/09/1999US5981806 Process for the preparation of hydroxynapthalenes
11/09/1999US5981572 Treatment of disorders which arise from a disturbed functioning of systems which are regulated by melatonin; in particular in the treatment of chronobiological disorders, especially in the elderly
11/09/1999US5980584 Substituted p-aminophenol, process of preparation and use in dyeing hair
11/03/1999EP0923544A4 Method for the synthesis of amines and amino acids with organoboron derivatives
11/02/1999US5977413 Method for producing bis(3-amino-4-hydroxyphenyl) compounds
11/02/1999US5977374 5-(4-hydroxy-OR 4-acetoxy-benzyl)-3- triphenylmethylthiazolidine-2,4-dione and method for producing same
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977147 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino- 1,3-propanediols and related compounds
10/1999
10/26/1999US5972991 Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/26/1999US5972044 Composition and method for dyeing keratin fibers
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 116